Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001154 · ClinicalTrials.gov registry record
Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 759
- Enrollment target
NCT00001154: Completed study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00001154 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 759 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001154 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 759 participants
- Enrollment target
Study Summary
Researchers plan to study the fat-rich particles, called lipoproteins, which circulate in the blood. This study is designed to improve understanding of normal, as well as abnormal, lipoprotein metabolism and the role it plays in the development of hardening of the arteries (atherosclerosis). Patients participating in this study will receive injections of lipoproteins or apolipoproteins (the protein component of lipoproteins) that have been isolated and purified. These lipoproteins will be labeled with small amounts of radioactive material and sterilized before they are injected into the patient. Patients participating in the study will be required to have blood samples taken, and provide urine samples throughout the course of the study. In addition, patient will be required to follow a specially formulated diet. Patients will be weighed throughout the course of the study.
Primary Outcome
Dyslipidemia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 759 participants |
| Start Date | 1976-09-03 |
What the finished NCT00001154 record still lists
NCT00001154 is an observational study that tracks outcomes without assigning an intervention. The registered 759 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00001154 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001154 about?
NCT00001154 is a clinical study titled "Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins". Researchers plan to study the fat-rich particles, called lipoproteins, which circulate in the blood. This study is designed to improve understanding of normal, as well as abnormal, lipoprotein metabolism and the role it plays in the development of hardening of the arteries (atherosclerosis). Patien...
What is the current status of trial NCT00001154?
This trial is currently completed. The enrollment target is 759 participants. The study started on 1976-09-03.
Who is sponsoring clinical trial NCT00001154?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02089607 · 760 participants · NA
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
- NCT04073706 · 760 participants · Phase 3
Sentinel Node Biopsy in Endometrial Cancer
- NCT05129228 · 760 participants · NA
Optical Coherence Tomography of the Saphenous Vein Graft
- NCT05787821 · 760 participants
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI